🔗 Permalink

Inventor profile of:

Jonathan Thomas Seal

City:

Stevenage

Country:

United Kingdom

Published Applications:

Last publication date:

2023-02-09

Top Assignees for applications by Jonathan Thomas Seal

The entities that hold a legal rights for patent applications filed by inventor Seal Jonathan Thomas:

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED 5 Brentford, Middlesex, United Kingdom
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED 4 Brentford, United Kingdom
GlaxoSmithKline Intellectual Property (No.2) Limited 4 Brentford, Middlesex, United Kingdom
Glaxosmithkline Intellectual Property (NO. 2) Limited 2 Middlesex, United Kingdom
GlaxoSmithKline LLC 2 Philadelphia, PA United States
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED 2 Middlesex, United Kingdom
GlaxoSmithKline LLC 1 Wilmington, New Castle, DE United States
GLAXO GROUP LIMITED 1 Greenford, Middlesex, United Kingdom

Recent patent applications by Seal Jonathan Thomas

Jonathan Thomas Seal from Stevenage, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-02-09

US20230040299A1

Human necessities

2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS

#2 | 2021-11-11

US20210346336A1

Human necessities

FURAN DERIVATIVES AS BROMODOMAIN INHIBITORS

#3 | 2021-02-18

US20210046073A1

Human necessities

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#4 | 2020-09-17

US20200291009A1

Chemistry; metallurgy

2,3-dihydrobenzohurans as bromodomain inhibitors

#5 | 2020-09-17

US20200289464A1

Human necessities

Benzofuran derivatives and their use as bromodomain inhibitors

#6 | 2020-01-09

US20200009140A1

Human necessities

Pyridyl derivatives as bromodomain inhibitors

#7 | 2019-12-19

US20190381010A1

Human necessities

Pyrazole derivatives as bromodomain inhibitors

#8 | 2019-11-28

US20190359572A1

Chemistry; metallurgy

Pyridinone dicarboxamide for use as bromodomain inhibitors

#9 | 2019-07-04

US20190202786A1

Chemistry; metallurgy

Pyridine dicarboxamide derivatives as bromodomain inhibitors

#10 | 2019-05-23

US20190151279A1

Human necessities

Benzo[b]furans as bromodomain inhibitors

#11 | 2019-04-25

US20190119248A1

Chemistry; metallurgy

Pyridyl derivatives as bromodomain inhibitors

#12 | 2018-10-25

US20180303831A1

Human necessities

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#13 | 2018-10-04

US20180282301A1

Chemistry; metallurgy

Pyridinone dicarboxamide for use as bromodomain inhibitors

#14 | 2018-10-04

US20180280368A1

Human necessities

2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors

#15 | 2018-09-13

US20180258044A1

Chemistry; metallurgy

Pyridinone dicarboxamide for use as bromodomain inhibitors

#16 | 2017-10-19

US20170298047A1

Chemistry; metallurgy

Tetrahydroquinoline derivatives as bromodomain inhibitors

#17 | 2017-07-06

US20170189401A1

Human necessities

2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#18 | 2016-01-21

US20160016908A1

Chemistry; metallurgy

2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors

#19 | 2014-03-06

US20140066459A1

Chemistry; metallurgy

Tetrahydroquinoline derivatives useful as bromodomain inhibitors

#20 | 2014-01-30

US20140031336A1

Chemistry; metallurgy

Tetrahydroquinoline derivatives useful as bromodomain inhibitors

#21 | 2010-10-07

US20100256364A1

Chemistry; metallurgy

Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases

InventorID:

632524 ⎘